Search - tctmd.com

Displaying 941 - 960 of 1548

Sort: Relevancy | Date

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

August 25, 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

August 25, 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

August 20, 2018

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

August 09, 2018

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

August 09, 2018

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

August 01, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

Black Patients Face Poorer Long-term Outcomes After In-Hospital Cardiac Arrest

News Daily News

Black Patients Face Poorer Long-term Outcomes After In-Hospital Cardiac Arrest

July 25, 2018

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

News Daily News

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

July 18, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

Once Again, ISCHEMIA Trial Feels the Squeeze

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

June 22, 2018

NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests

News Daily News

NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests

June 21, 2018

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

June 19, 2018

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

News Daily News

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

June 14, 2018

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

June 07, 2018

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

June 04, 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

May 31, 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.